Abdominal Cancer Clinical Trials

Local doctors are looking for people dealing with pain from radiculopathy (sciatic) for clinical research studies of an investigational medication. Doctors are studying this medication to see if it may provide relief from common symptoms often associated with radiculopathy pain.  

The RELIEF study is a prospective, multi-center, global registry of Boston Scientific neurostimulation systems for pain. The goal of the RELIEF study is to collect information about adult chronic pain patients who are using a Boston Scientific neurostimulation system.  

The COMBO Study is a clinical research study designed to evaluate the effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities as compared to conventional SCS in patients with chronic pain when using the Boston Scientific Spectra WaveWriter SCS System. The WaveWriter SCS System will be evaluated based on how ...

The study will consist of 6 office visits and 5 phone calls. Participants will be randomly assigned to receive a combination of guanfacine, morphine, or placebo. Participants will be asked to provide one blood sample, multiple urine samples for drug screen analysis, fill out questionnaires, and undergo sensitivity tests to ...

The study will consist of 4 office visits and 2 phone calls. Participants will be randomly assigned to receive either guanfacine or placebo. Participants will be asked to provide one blood sample, multiple urine samples for drug screen analysis, fill out questionnaires, and undergo sensitivity tests to hot and cold ...

The study is a randomized controlled study with careful controls. Our study population is comprised of 240 BC patients in palliative and curative care (comprised of 50% Jewish and 50% Arab). This population will be randomized to receive a standard art therapy intervention or a comparison group. The AT intervention ...

Study ROR-PH-301 is a multicenter, randomized, double-blind, placebo-controlled study. Subjects who meet entry criteria will be randomly allocated 1:1 to receive ralinepag or placebo, in addition to their standard of care or PAH-specific background therapy, as applicable. The primary endpoint is the time (in days) from randomization to the first ...

Pediatric PAH is a rare and progressive disorder associated with considerable morbidity and mortality. Given the significant medical need to develop treatments in children with PAH, further clinical studies in the pediatric population are therefore needed to provide more data for the management of PAH in children. Selexipag (JNJ-67896049) is ...

44 patients, uindergoing radical cystectomy, aging 18-85 will be recruited based on a power calculation. The 44 patients will be divided in 2 groups, the intervention group receiving a quadratus lumborum block (75mg ropivacaine) and the no intervention group receiving the current standard care of our hospital -an epidural. The ...

Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and cluster-randomized open-label ...